AZD-7594
| CAS No. | 1196509-60-0 | Cat. No. | BCP20443 |
| Name | AZD-7594 | ||
| Synonyms | AZD 7594; AZD7594; AZ13189620; AZ-13189620; AZ 13189620; | ||
| Formula | C32H32F2N4O6 | M. Wt | 606.62 |
| Description | AZD-7594, also known as AZ13189620, is an inhaled selective glucocorticoid receptor (GCCR) modulator. AZD-7594 is in phase II clinical trials by AstraZeneca for the treatment of mild to moderate asthma. It is also in phase I clinical trials for the treatment of chronic obstructive pulmonary disorder (COPD). | ||
| Pathways | GPCR/G Protein | ||
| Targets | Glucocorticoid Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.